|
1
|
A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt.
|
Liver Int
|
2011
|
3.69
|
|
2
|
Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma.
|
Eur J Cancer
|
2011
|
2.81
|
|
3
|
Estimation of the healthy upper limits for serum alanine aminotransferase in Asian populations with normal liver histology.
|
Hepatology
|
2010
|
2.38
|
|
4
|
Efficacy of entecavir in treatment-naïve patients with hepatitis B virus-related decompensated cirrhosis.
|
J Hepatol
|
2009
|
2.21
|
|
5
|
Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion.
|
J Gastroenterol Hepatol
|
2009
|
2.16
|
|
6
|
Increased risk of adefovir resistance in patients with lamivudine-resistant chronic hepatitis B after 48 weeks of adefovir dipivoxil monotherapy.
|
Hepatology
|
2006
|
1.93
|
|
7
|
Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: long-term patient outcomes.
|
Int J Radiat Oncol Biol Phys
|
2011
|
1.78
|
|
8
|
Noninvasive diagnostic criteria for hepatocellular carcinoma in hepatic masses >2 cm in a hepatitis B virus-endemic area.
|
Liver Int
|
2011
|
1.77
|
|
9
|
Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein.
|
Gastroenterology
|
2007
|
1.68
|
|
10
|
Efficacy of entecavir in patients with chronic hepatitis B resistant to both lamivudine and adefovir or to lamivudine alone.
|
Hepatology
|
2009
|
1.66
|
|
11
|
Sorafenib for hepatocellular carcinoma according to Child-Pugh class of liver function.
|
Cancer Chemother Pharmacol
|
2011
|
1.61
|
|
12
|
Non-invasive assessment of hepatic steatosis: prospective comparison of the accuracy of imaging examinations.
|
J Hepatol
|
2010
|
1.61
|
|
13
|
A nationwide seroepidemiology of hepatitis C virus infection in South Korea.
|
Liver Int
|
2013
|
1.57
|
|
14
|
Recurrences of hepatocellular carcinoma following initial remission by transcatheter arterial chemoembolization.
|
J Gastroenterol Hepatol
|
2002
|
1.37
|
|
15
|
Which response criteria best help predict survival of patients with hepatocellular carcinoma following chemoembolization? A validation study of old and new models.
|
Radiology
|
2011
|
1.36
|
|
16
|
Clinical outcome of 251 patients with extrahepatic metastasis at initial diagnosis of hepatocellular carcinoma: does transarterial chemoembolization improve survival in these patients?
|
J Gastroenterol Hepatol
|
2011
|
1.23
|
|
17
|
Suppressive effects of entecavir on hepatitis B virus and hepatocellular carcinoma.
|
J Gastroenterol Hepatol
|
2011
|
1.12
|
|
18
|
Recent increase in antibiotic-resistant microorganisms in patients with spontaneous bacterial peritonitis adversely affects the clinical outcome in Korea.
|
J Gastroenterol Hepatol
|
2003
|
1.12
|
|
19
|
Transforming growth factor-beta1 as a useful serologic marker of small hepatocellular carcinoma.
|
Cancer
|
2002
|
1.09
|
|
20
|
Adiponectin and adiponectin receptor in relation to colorectal cancer progression.
|
Int J Cancer
|
2010
|
1.08
|
|
21
|
Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinoma.
|
Ann Surg Oncol
|
2009
|
1.05
|
|
22
|
Sorafenib for recurrent hepatocellular carcinoma after liver transplantation.
|
Jpn J Clin Oncol
|
2010
|
1.05
|
|
23
|
Combination of transarterial chemoembolization and three-dimensional conformal radiotherapy for hepatocellular carcinoma with inferior vena cava tumor thrombus.
|
Int J Radiat Oncol Biol Phys
|
2009
|
1.04
|
|
24
|
Identification of hepatitis C virus genotype 6 in Korean patients by analysis of 5' untranslated region using a matrix assisted laser desorption/ionization time of flight-based assay, restriction fragment mass polymorphism.
|
J Med Virol
|
2008
|
1.04
|
|
25
|
Lamivudine plus adefovir or entecavir for patients with chronic hepatitis B resistant to lamivudine and adefovir.
|
J Hepatol
|
2010
|
1.04
|
|
26
|
Long-term additional lamivudine therapy enhances durability of lamivudine-induced HBeAg loss: a prospective study.
|
J Hepatol
|
2003
|
1.03
|
|
27
|
Emergency adult-to-adult living-donor liver transplantation for acute liver failure in a hepatitis B virus endemic area.
|
Hepatology
|
2010
|
0.99
|
|
28
|
Randomized trial of entecavir plus adefovir in patients with lamivudine-resistant chronic hepatitis B who show suboptimal response to lamivudine plus adefovir.
|
Antimicrob Agents Chemother
|
2012
|
0.97
|
|
29
|
Sorafenib dose escalation in the treatment of advanced hepatocellular carcinoma.
|
Oncology
|
2012
|
0.96
|
|
30
|
Entecavir plus adefovir combination treatment for chronic hepatitis B patients after failure of nucleoside/nucleotide analogues.
|
Antivir Ther
|
2012
|
0.95
|
|
31
|
[A case of acute hepatitis a complicated by Guillain-Barré syndrome].
|
Korean J Hepatol
|
2007
|
0.94
|
|
32
|
Lens culinaris agglutinin-reactive alpha-fetoprotein as a prognostic marker in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization.
|
J Clin Gastroenterol
|
2002
|
0.93
|
|
33
|
Complete necrosis after transarterial chemoembolization could predict prolonged survival in patients with recurrent intrahepatic hepatocellular carcinoma after curative resection.
|
Ann Surg Oncol
|
2009
|
0.91
|
|
34
|
Role of additional angiography and chemoembolization in patients with hepatocellular carcinoma who achieved complete necrosis following transarterial chemoembolization.
|
J Gastroenterol Hepatol
|
2004
|
0.91
|
|
35
|
Preoperative portal vein embolization and surgical resection in patients with hepatocellular carcinoma and small future liver remnant volume: comparison with transarterial chemoembolization.
|
Ann Surg Oncol
|
2007
|
0.90
|
|
36
|
Focal nodular hyperplasia or focal nodular hyperplasia-like lesions of the liver: a special emphasis on diagnosis.
|
J Gastroenterol Hepatol
|
2011
|
0.89
|
|
37
|
Hepatic myelopathy as a presenting neurological complication in patients with cirrhosis and spontaneous splenorenal shunt.
|
Korean J Hepatol
|
2008
|
0.88
|
|
38
|
Characteristic clinical features of hepatocellular carcinoma associated with Budd-Chiari syndrome: evidence of different carcinogenic process from hepatitis B virus-associated hepatocellular carcinoma.
|
Eur J Gastroenterol Hepatol
|
2004
|
0.88
|
|
39
|
Four cases of hepatitis B virus-related fibrosing cholestatic hepatitis treated with lamivudine.
|
J Gastroenterol Hepatol
|
2002
|
0.88
|
|
40
|
Production of cellulosic ethanol in Saccharomyces cerevisiae heterologous expressing Clostridium thermocellum endoglucanase and Saccharomycopsis fibuligera beta-glucosidase genes.
|
Mol Cells
|
2009
|
0.88
|
|
41
|
[Nine cases of sporadic acute hepatitis E in Korea].
|
Korean J Hepatol
|
2006
|
0.88
|
|
42
|
Applicability of the BCLC staging system to patients with hepatocellular carcinoma in Korea: analysis at a single center with a liver transplant center.
|
Korean J Hepatol
|
2011
|
0.87
|
|
43
|
The characteristics of bio-oil produced from the pyrolysis of three marine macroalgae.
|
Bioresour Technol
|
2010
|
0.86
|
|
44
|
[Clinical and microbiological characteristics of spontaneous bacterial peritonitis (SBP) in a recent five year period].
|
Taehan Kan Hakhoe Chi
|
2002
|
0.86
|
|
45
|
Maximum number of target lesions required to measure responses to transarterial chemoembolization using the enhancement criteria in patients with intrahepatic hepatocellular carcinoma.
|
J Hepatol
|
2011
|
0.86
|
|
46
|
[Usefulness of reagent strips for the diagnosis of spontaneous bacterial peritonitis].
|
Korean J Hepatol
|
2005
|
0.86
|
|
47
|
High effectiveness of peginterferon alfa-2a plus ribavirin therapy in Korean patients with chronic hepatitis C in clinical practice.
|
Clin Mol Hepatol
|
2013
|
0.85
|
|
48
|
Which patients with chronic hepatitis B are more likely to relapse after interferon alpha-induced hepatitis B e antigen loss in Korea?
|
J Clin Gastroenterol
|
2004
|
0.84
|
|
49
|
Bio-oil production from fast pyrolysis of waste furniture sawdust in a fluidized bed.
|
Bioresour Technol
|
2009
|
0.84
|
|
50
|
rtL180M mutation of hepatitis B virus is closely associated with frequent virological resistance to adefovir dipivoxil therapy.
|
J Gastroenterol Hepatol
|
2012
|
0.84
|
|
51
|
Precore stop codon mutation of hepatitis B virus is associated with low breakthrough rate following long-term lamivudine therapy.
|
J Gastroenterol Hepatol
|
2005
|
0.83
|
|
52
|
Production of minicellulosomes from Clostridium cellulovorans for the fermentation of cellulosic ethanol using engineered recombinant Saccharomyces cerevisiae.
|
FEMS Microbiol Lett
|
2010
|
0.83
|
|
53
|
Combination of alpha-interferon with lamivudine reduces viral breakthrough during long-term therapy.
|
J Gastroenterol Hepatol
|
2004
|
0.81
|
|
54
|
[Clinical features of fulminant hepatic failure in a tertiary hospital with a liver transplant center in Korea].
|
Korean J Hepatol
|
2006
|
0.80
|
|
55
|
Susceptibility to type 1 autoimmune hepatitis is associated with shared amino acid sequences at positions 70-74 of the HLA-DRB1 molecule.
|
J Hepatol
|
2007
|
0.80
|
|
56
|
Direct detection of lamivudine-resistant hepatitis B virus mutants by a multiplex PCR using dual-priming oligonucleotide primers.
|
J Virol Methods
|
2008
|
0.80
|
|
57
|
Current approaches for treating chronic hepatitis B: when to start, what to start with, and when to stop.
|
Hepatol Int
|
2008
|
0.79
|
|
58
|
Current antiviral therapy for chronic hepatitis B.
|
J Korean Med Sci
|
2004
|
0.79
|
|
59
|
Cholestyramine resin for erythropoietic protoporphyria with severe hepatic disease: a case report.
|
Korean J Hepatol
|
2010
|
0.78
|
|
60
|
Cellulose pretreatment with 1-n-butyl-3-methylimidazolium chloride for solid acid-catalyzed hydrolysis.
|
Bioresour Technol
|
2010
|
0.78
|
|
61
|
Hepatitis B virus with the rtL80V/I mutation is associated with a poor response to adefovir dipivoxil therapy.
|
Liver Int
|
2009
|
0.78
|
|
62
|
Prognostic value of serum osteopontin in hepatocellular carcinoma patients treated with transarterial chemoembolization.
|
Korean J Hepatol
|
2009
|
0.78
|
|
63
|
[Therapeutic efficacy of lamivudine in patients with hepatitis B virus-related decompensated cirrhosis in Korea].
|
Taehan Kan Hakhoe Chi
|
2002
|
0.77
|
|
64
|
[Therapeutic efficacy of transjugular intrahepatic portosystemic shunt on bleeding gastric varices].
|
Taehan Kan Hakhoe Chi
|
2002
|
0.77
|
|
65
|
Clinical course of chronic hepatitis B patients who were off-treated after lamivudine treatment: analysis of 138 consecutive patients.
|
Virol J
|
2012
|
0.77
|
|
66
|
Neural cadherin overexpression is a predictive marker for early postoperative recurrence in hepatocellular carcinoma patients.
|
J Gastroenterol Hepatol
|
2007
|
0.76
|
|
67
|
Randomized trial of the virologic response during up to two years of entecavir-adefovir combination therapy in multiple-drug-refractory chronic hepatitis B virus patients.
|
Antimicrob Agents Chemother
|
2013
|
0.76
|
|
68
|
Osler-Weber-Rendu disease presenting with hepatocellular carcinoma: radiologic and genetic findings.
|
Korean J Hepatol
|
2011
|
0.75
|
|
69
|
Could HBx protein expression affect signal pathway inhibition by gefitinib or selumetinib, a MEK inhibitor, in hepatocellular carcinoma cell lines?
|
J Korean Med Sci
|
2011
|
0.75
|
|
70
|
Individualization of interferon therapy using serum hepatitis B virus DNA to reduce viral relapse in patients with chronic hepatitis B: a randomized controlled trial.
|
Eur J Gastroenterol Hepatol
|
2003
|
0.75
|
|
71
|
Biochemical Rather than Virologic Response to Interferon Therapy may be More Closely Associated with Decrease of Hepatocellular Carcinoma Incidence in Patients with Chronic Hepatitis B.
|
Gut Liver
|
2007
|
0.75
|
|
72
|
Application of mesoporous Al-MCM-48 material to the conversion of lignin.
|
J Nanosci Nanotechnol
|
2014
|
0.75
|
|
73
|
[The effects of tamoxifen on human hepatocellular carcinoma cell proliferation and transforming growth factor-beta1 expression].
|
Taehan Kan Hakhoe Chi
|
2003
|
0.75
|
|
74
|
Lamivudine therapy for decompensated liver cirrhosis related to hepatitis B virus infection.
|
Intervirology
|
2003
|
0.75
|
|
75
|
The stability of platinum-carbon aerogel catalysts upon repeated potential cycles.
|
ChemSusChem
|
2009
|
0.75
|
|
76
|
Highly Dispersed Pt Nanoparticles for the Production of Aromatic Hydrocarbons by the Catalytic Degrading of Alkali Lignin.
|
J Nanosci Nanotechnol
|
2016
|
0.75
|
|
77
|
Clinical usefulness of endoscopic palliation in patients with biliary obstruction caused by hepatocellular carcinoma.
|
Digestion
|
2013
|
0.75
|
|
78
|
Catalytic Depolymerization of Alkali Lignin Using Supported Pt Nanoparticle Catalysts.
|
J Nanosci Nanotechnol
|
2016
|
0.75
|
|
79
|
Catalytic upgrading of xylan over mesoporous Y catalyst.
|
J Nanosci Nanotechnol
|
2014
|
0.75
|
|
80
|
[Validation of international autoimmune hepatitis group scoring system for diagnosis of type 1 autoimmune hepatitis in Korea].
|
Taehan Kan Hakhoe Chi
|
2002
|
0.75
|
|
81
|
[Mutations within the interferon sensitivity determining region in Korean patients infected with hepatitis C virus genotype 1b].
|
Korean J Hepatol
|
2010
|
0.75
|
|
82
|
In situ catalytic pyrolysis of miscanthus over modified SBA-15 catalysts using Py-GC/MS.
|
J Nanosci Nanotechnol
|
2014
|
0.75
|
|
83
|
Catalytic fast pyrolysis of lignin over mesoporous Y zeolite using Py-GC/MS.
|
J Nanosci Nanotechnol
|
2013
|
0.75
|
|
84
|
Antifibrogenic effects of tamoxifen in a rat model of periportal hepatic fibrosis.
|
Liver Int
|
2008
|
0.75
|
|
85
|
Catalytic Reforming of Lignin-Derived Bio-Oil Over a Nanoporous Molecular Sieve Silicoaluminophosphate-11.
|
J Nanosci Nanotechnol
|
2016
|
0.75
|